Cargando…
Isolated Adrenocorticotropic Hormone Deficiency Caused by Nivolumab in a Patient with Metastatic Lung Cancer
Nivolumab has promising efficacy for treating various advanced malignant tumors, although it has been reported to induce a wide range of autoimmune adverse effects. We herein report the case of a patient with metastatic lung adenocarcinoma who developed adrenal insufficiency after 12 cycles of nivol...
Autores principales: | Takaya, Kazuhiko, Sonoda, Miwa, Fuchigami, Ayako, Hiyoshi, Toru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643175/ https://www.ncbi.nlm.nih.gov/pubmed/28824067 http://dx.doi.org/10.2169/internalmedicine.8548-16 |
Ejemplares similares
-
Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report
por: Takeno, Ayumu, et al.
Publicado: (2019) -
A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency
por: Sato, Yozo, et al.
Publicado: (2019) -
Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report
por: Simeni Njonnou, Sylvain Raoul, et al.
Publicado: (2022) -
A case of small-cell lung cancer with adrenocorticotropic hormone deficiency induced by nivolumab
por: Zhu, Yan, et al.
Publicado: (2019) -
A Case of Isolated Adrenocorticotropic Hormone Deficiency Caused by Pembrolizumab
por: Bekki, Tomoaki, et al.
Publicado: (2020)